EndoTODAY | EndoATLAS | ¿Ü·¡¼³¸íÀÚ·á

±â»ýÃæ | ½Äµµ | À§ | À§¾Ï | ESD | õ±â´©¼³

Home | Guide | ÁÖÀÎÀå | ±¸µ¶ | °Ë»ö | ¸µÅ©


[ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½ÉÁý´ãȸ 2016-4-7]

Previous | Next

1. Change of EGC morphology probably by PPI

À§°¢ÀÇ ÇÔ¸ôÇü º´¼Ò¿¡¼­ Á¶Á÷°Ë»çÇÏ¿© atypical cellÀÌ ÀÖ´Ù°í ÀǷڵǾú½À´Ï´Ù. °Ë»ç Á÷ÈĺÎÅÍ PPI¸¦ µå½Å °Í °°½À´Ï´Ù. ¾à 4ÁÖ ÈÄ ³»½Ã°æ¿¡¼­ ±Ë¾çÇü º´¼Ò´Â °ÅÀÇ ¾Æ¹°¾î ÀÖ¾ú½À´Ï´Ù. ¿ÜºÎ Á¶Á÷°Ë»ç ÀçÆǵ¶°ú º» º´¿øÀÇ ³»½Ã°æ Á¶Á÷°Ë»ç Àç°Ë¿¡¼­ ¸ðµÎ ¾ÏÀ¸·Î ³ª¿Í ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù. º» º´¿ø¿¡¼­´Â PPI¸¦ µå¸®Áö ¾Ê¾Ò°í ¾à 2ÁÖ ÈÄ ¼ö¼úÇÏ¿´½À´Ï´Ù. ¼ö¼ú Àü³¯ clippingÀ» À§ÇÏ¿© ³»½Ã°æ Àç°ËÀ» ÇÏ¿´½À´Ï´Ù. 3¹øÀÇ ³»½Ã°æ »çÁøÀ» Àß º¸½Ã±â ¹Ù¶ø´Ï´Ù. Á¶±âÀ§¾ÏÀº natural history¿¡ ÀÇÇÏ¿© ¸ð¾çÀÌ º¯Çϱ⵵ ÇÏÁö¸¸ PPI µî ¾àÁ¦¿¡ ÀÇÇÑ ¿µÇâµµ »ó´çÇÕ´Ï´Ù.

Early gastric carcinoma
1. Location : lower third, Center at body and lesser curvature
2. Gross type : EGC type IIc and IIa
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size : 3.9x2.5 cm
6. Depth of invasion : invades mucosa (muscularis mucosae) (pT1a)
7. Resection margin: free from carcinoma, safety margin: proximal 3.5 cm, distal 6.3 cm
8. Lymph node metastasis : no metastasis in 65 regional lymph nodes (pN0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. AJCC stage by 7th edition: pT1a N0


À§¾ÏÀÇ ÀÚ¿¬»ç¸¦ º¸¿©ÁØ °ú°Å Áõ·Ê¸¦ ¼Ò°³ÇÕ´Ï´Ù.

70´ë ³²ÀÚÀÔ´Ï´Ù. Cardia¸¦ involveÇÏ´Â À§¾ÏÀ¸·Î ¼ö¼úÀ» ±ÇÇÏ¿´À¸³ª ¼ö¼úÇÏÁö ¾Ê°í °æ°ú°üÂûÀ» ¿øÇϽþî follow-up loss°¡ µÇ¾ú´Ù°¡ 1´Þ ÀüºÎÅÍ dysphagia°¡ ÀÖ¾î ÀÇ·ÚµÈ È¯ÀÚÀÔ´Ï´Ù. 18 °³¿ù Àü »çÁøÀ» º¸¸é º´¼ÒÀÇ distal marginÀº upper body¿Í mid-bodyÀÇ °æ°è Á¤µµ¿´À¸³ª ÃÖ±Ù ³»½Ã°æ¿¡¼­´Â cardia involve°¡ ÀÖ¾ú°í (»çÁø»ý·«), angle±îÁö º´¼Ò°¡ ³Ð¾îÁ³½À´Ï´Ù. ºñ±³Àû ºü¸¥ ¼ÓµµÀÇ progressionÀ» º¸ÀÎ ÁøÇ༺À§¾ÏÀ̾ú´ø °ÍÀ¸·Î ÆÇ´ÜÇÏ¿´½À´Ï´Ù.

°ú°Å¿¡´Â °í·ÉÀÇ È¯Àڵ鿡°Ô ¼ö¼úÀ» ±ÇÇÏ´Â °ÍÀº ¸Å¿ì ¾î·Æ°í À§ÇèÇÑ ÀÏ·Î °£ÁֵǾú½À´Ï´Ù. ±×·¯³ª ÃÖ±Ù¿¡´Â °í·ÉÀÇ È¯ÀÚ¶ó°í ÇÏ´õ¶óµµ performance°¡ ÁÁÀº °æ¿ì´Â Àû±ØÀûÀÎ Ä¡·á¸¦ ±ÇÇÏ´Â °ÍÀÌ º¸ÅëÀÔ´Ï´Ù. ¼ö¼ú¿¡ µû¸¥ À§Ç輺Àº ½ÇÁ¦ ¿¬·Éº¸´Ù´Â cardiopulmonary function¿¡ ÀÇÇÏ¿© °áÁ¤µÇ´Â °ÍÀ¸·Î »ý°¢µÇ±â ¶§¹®ÀÔ´Ï´Ù. ¼ö¼úÀÌ °¡´ÉÇÑ ÁøÇ༺À§¾Ï ȯÀÚ¿¡¼­ ÃÊ°í·É ȯÀÚ¶ó°í ÇÏ´õ¶óµµ Áß³â ȯÀÚ¿¡ ºñÇÏ¿© ¼ö¼ú¿¡ µû¸¥ morbidity¿Í mortality°¡ À¯ÀÇÇÑ Â÷ÀÌ°¡ ¾ø´Ù´Â °ÍÀº ¿©·¯ º¸°í¿¡¼­ ¹Ýº¹ÀûÀ¸·Î È®Àεǰí ÀÖ½À´Ï´Ù.

¾î¶² ¼±»ý´ÔÀº ÀÌ·± ¸»¾¸À» Çϼ̽À´Ï´Ù. "³ªÀÌ´Â ´ÜÁö ¼ýÀÚÀÏ »ÓÀÌ´Ù."


2. Pylorus¿¡ ´ê¾ÆÀÖ´Â ÁøÇ༺ À§¾Ï

Advanced gastric carcinoma
1. Location : [1] lower third, [2] duodenum, Center at antrum and lesser curvature
2. Gross type : Borrmann type 2
3. Histologic type : tubular adenocarcinoma, poorly differentiated
4. Histologic type by Lauren : diffuse
5. Size : 4x3.1 cm
6. Depth of invasion : invades muscularis propria (pT2)
7. Resection margin: free from carcinoma
8. Lymph node metastasis : metastasis to 5 out of 30 regional lymph nodes (pN2) (5/30: "1", 0/4; "3", 1/10; "4", 1/2; "4sb", 0/1; "5", 1/1; "6", 1/4; "8a", 0/3; "7", 0/2; "9", 0/0; "11p", 0/2; "12a", 1/1)
9. Lymphatic invasion : present
10. Venous invasion : not identified
11. Perineural invasion : not identified
12. Peritoneal cytology : negative
13. AJCC stage by 7th edition: pT2 N2

»ý°¢º¸´Ù ¸²ÇÁÀý ÀüÀÌ°¡ ÇöÀúÇß½À´Ï´Ù. 3¹ø, 4¹ø, 5¹ø, 6¹ø, 12a¹ø¿¡ °¢°¢ ÀüÀ̵Ǿî ÀÖ¾ú½À´Ï´Ù. ¾Æ·¡ lymph node stationÀ» ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.


3. 8³âÀü hilar mass (diffuse large B cell lymphoma)·Î Ç×¾ÏÄ¡·á ¹Þ´ø ȯÀÚÀÇ gastric recurrence

À§ ¸²ÇÁÁ¾Àº °£È¤ Borrmann type II¿Í ±¸ºÐÀÌ ¾î·Æ½À´Ï´Ù. ÀÌ È¯ÀÚ´Â gastric biopsy¿¡¼­µµ diffuse large B cell lymphoma°¡ ³ª¿Ô½À´Ï´Ù.

* Âü°í: EndoTODAY diffuse large B cell lymphoma


4. 60 ´ë ¿©. EGC. ESD ½ÃµµÇÏ¿´À¸³ª ±í¾î¼­ ¼ö¼úÀ» ÇÏ¿´½À´Ï´Ù.

Stomach, endoscopic submucosal dissection:
Early gastric carcinoma
1. Location : antrum, lesser curvature
2. Gross type : EGC type IIa & IIc
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size of carcinoma : (1) longest diameter, 20 mm (2) vertical diameter, 17 mm
6. Depth of invasion : invades submucosa, (depth of sm invasion : 3000 §­) (pT1b)
7. Resection margin : involved deep resection margin by carcinoma, safety margin : distal 8 mm, proximal 6 mm, anterior 6 mm, posterior 6 mm, deep 0 mm
8. Lymphatic invasion : present
9. Venous invasion : not identified(N)
10. Perineural invasion : not identified(N)
11. Microscopic ulcer : absent
12. Histologic heterogeneity: absent


5. 40 ´ë ¿©. Actinomycosis (º¹ºÎ ¹æ¼±±ÕÁõ)

2014³â Áõ·ÊÀÔ´Ï´Ù. LUQ pain, hematochezia, weight loss 3~4kg/10days µîÀ¸·Î CT¸¦ ½ÃÇàÇÏ°í "colon(splenic flexure) wall thickening with omentum invasion ÀÖ¾î r/o colon ca, r/o metastatic cancer" ¼Ò°ßÀ¸·Î ÀǷڵǾú½À´Ï´Ù. ´ëÀå³»½Ã°æ°ú CT Æǵ¶À» ÇÏ¿´½À´Ï´Ù. CT Æǵ¶ÀÌ ¸Å¿ì ÈǸ¢Çß½À´Ï´Ù.

CT Æǵ¶: Left sideÀÇ gastrocolic ligament¸¦ µû¶ó¼­ irregular enhancing mass°¡ ÀÖÀ½. °æ°è°¡ ÁÁÁö ¾Ê¾Æ Å©±âÀÇ ÃøÁ¤¿¡ Á¦ÇÑÀÌ ÀÖÀ¸³ª 6 cm ÀÌ»óÀÇ extent¸¦ º¸ÀÓ. ÀÌ º´º¯Àº »ó¹æÀ¸·Î stomachÀÇ body greater curvature side¿Í ÇϹæÀ¸·Î´Â transverse colonÀÇ upper wall±îÁö extensionÇÏ°í ÀÖÀ½. InvolvementµÈ bowel wall thickeningÀÌ ÀÖÀ¸³ª ºñ±³Àû layeringÀÌ À¯ÁöµÇ°í ÀÖÀ½. ±×·¯³ª transverse colon¿¡¼­´Â focalÇÏ°Ô layeringÀÌ À¯ÁöµÇÁö ¾Ê´Â ºÎºÐÀÌ ÀǽɵÊ. Left side mesorectum¿¡ ¾à 3.3 cm sizeÀÇ enhancing mass°¡ ÀÖ°í ¿ª½Ã °æ°è°¡ ÁÁÁö ¾ÊÀ¸¸ç ÁÖº¯À¸·Î infiltrationÀ» µ¿¹ÝÇÏ°í ÀÖÀ½. RectumÀÇ left side wall°ú abuttingÇÏ°í ÀÖÀ¸¸ç ÀÎÁ¢ÇÑ rectal wall¿¡ wall thickeningÀÌ ÀÖ°í ¿ª½Ã layeringÀÌ À¯ÁöµÇ°í ÀÖÀ½. Pelvic cavity¿¡ ¼Ò·®ÀÇ fluid collectionÀÌ ÀÖÀ½. Uterus¿¡ IUD insertion stateÀÓ. º¹°­ ³» ÀǹÌÀÖ°Ô Ä¿Áø lymph node º¸ÀÌÁö ¾ÊÀ½. ±× ¿Ü liver¿Í spleen, pancreas, both kidneys¿¡ ƯÀÌ¼Ò°ß ¾øÀ½. GB¿¡ ƯÀÌ¼Ò°ß ¾ø°í biliary tree dilatation ¾øÀ½. Scan¿¡ Æ÷ÇÔµÈ basal lung°ú bone¿¡ ƯÀÌ¼Ò°ß ¾øÀ½.
CONCLUSION: Inflammatory lesion such as actinomycosis R/O Malignancy such as transverse colon cancer with peritoneal seeding.
RECOMMENDATION: Transrectal biopsy for mesorectal mass.

Transvaginal biopsy¸¦ ½ÃÇàÇÏ¿´°í ´ÙÀ½ÀÇ °á°ú¿´½À´Ï´Ù. Inflamed granulation tissue with abscess and dense fibrosis. Bacterial colony present, consistent with actinomycosis

Treatment: IV penicillin G


2017³â 3¿ù ³»½Ã°æÇÐȸ ±³À°ÀÚ·á°¡ º¹ºÎ ¹æ¼±±ÕÁõ (actinomycosis) À̾ú½À´Ï´Ù.


[References]

1) SMC Endoscopy Unit »ï¼º¼­¿ïº´¿ø ³»½Ã°æ½Ç

2) SMC Monday GI conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒÈ­±âÁý´ãȸ

3) SMC Thursday endoscopy conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ

© EndoTODAY Endoscopy Learninng Center. Jun Haeng Lee.